Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bristol-Myers Squibb

Bristol-Myers Squibb
1887 FOUNDED
PUBLIC STATUS
20K-25K EMPLOYEES
BMY STOCK SYMBOL
51 INVESTMENTS
$45.80 SHARE PRICE (As of Wednesday Closing)
Description

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Stock Exchange
NYS
Primary Office
  • 430 East 29th Street
  • 14th Floor
  • New York, NY 10016
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bristol-Myers Squibb’s full profile, request a free trial.

Bristol-Myers Squibb Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$44.30 - $63.69 $74.4B $46.02 $3.01 18.8M 1.63B

Bristol-Myers Squibb Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 85,428,692 86,097,692 100,824,957 100,243,678
Revenue 22,561,000 22,561,000 20,776,000 19,427,000
EBITDA 6,788,000 6,788,000 6,116,000 6,464,000
Net Income 4,920,000 4,920,000 1,007,000 4,457,000
Total Assets 34,986,000 34,986,000 33,551,000 33,707,000
Total Debt 7,349,000 7,349,000 7,962,000 6,708,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bristol-Myers Squibb Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb‘s full profile, request access.

Request full access to PitchBook

Bristol-Myers Squibb Investments & Acquisitions (51)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 28-Mar-2019 00000 00000 00 000.00 Biotechnology
0000000 03-Jan-2019 000000000000000000 000.00 Biotechnology 00000000 0000000 00
0000000 26-Oct-2018 00000 00000 00 0000 Drug Discovery
00000000 12-Oct-2018 0000 0000 Drug Delivery 00000 0000000 00
Nektar Therapeutics 08-Aug-2018 PIPE 00.000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Bristol-Myers Squibb Exits (12)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 20-Jun-2011 00000 00000 00 0000 Completed
  • 0000000-00000 0000
000000 05-Aug-2009 00000 00000 00 000.00 Completed
  • 9 buyers
00000 00000000000 14-Nov-2007 00000 00000 00 000.00 Completed
  • 15 buyers
0000000000 17-Oct-2003 00000 00000 00 0000 Completed
  • 4 buyers
ImClone Systems 01-Sep-2001 Secondary Transaction - Private 000 Completed
To view this company’s complete exits history, request access »

Bristol-Myers Squibb Subsidiaries (8)

Company Name Industry Location Founded
IFM Therapeutics Drug Discovery Boston, MA 2015
0000000 Drug Discovery Copenhagen North, Denmark 0000
000000000 Biotechnology Lexington, MA 0000
0000000-00000 0000 Foundation New York, NY 0000
000000000000 Drug Discovery Seattle, WA 0000
To view this company’s complete subsidiary history, request access »

Bristol-Myers Squibb Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb‘s full profile, request access.

Request full access to PitchBook

Bristol-Myers Squibb Executive Team (43)

Name Title Board
Seat
Contact
Info
Giovanni Caforio MD Chairman of the Board and Chief Executive Officer
Charles Bancroft Executive Vice President, Chief Financial Officer and Global Business Operations
Jitendra Tyagi Managing Director, India
Adam Dubow JD Senior Vice President & Chief Compliance and Ethics Officer
Ann Judge Senior Vice President and Chief Human Resources Officer

17 Former Executives

You’re viewing 5 of 43 executives. Get the full list »

Bristol-Myers Squibb Board Members (8)

Name Representing Role Since Contact
Info
0000 0000 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000
00000000 0000000 00 Bristol-Myers Squibb Chairman of the Board and Chief Executive Officer 000 0000
0000000 000000000 Self Board Member 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »